ALEXA KAUFMAN: Open Payments
NPI 1164076063 · DUBLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$986 in 47 payments from 10 companies in 2025. Trend: 2023 $515 · 2024 $805 · 2025 $986
Food & beverage: $780Education: $206
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $421 |
| ABBVIE INC. | 16 | $247 |
| Supernus Pharmaceuticals, Inc. | 7 | $133 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Bausch Health US, LLC | 2 | $40 |
| Almatica Pharma LLC | 1 | $29 |
| Biogen, Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Tris Pharma Inc | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: VRAYLAR, AUSTEDO XR, Qelbree, Auvelity, LOREEV XR, Sunosi, APLENZIN, UZEDY.
Industry payments across OH — which companies pay providers there.
